Is the ban on pharmacy advertising in Poland set to end? On June 19, 2025, the Court of Justice of the European Union, in Case C-200/24, determined that Article 94a Section 1 of the Pharmaceutical Law Act, which fully bans pharmacy advertising, is inconsistent with EU law.

What does this mean in practice?

• It enables the reopening of proceedings and the recovery of fines paid in connection with an alleged violation of the advertising ban. However, please note that entrepreneurs have only one month from the publication of the judgment in the Official Journal of the EU to submit an application for reopening.
• It offers new marketing perspectives for pharmacies – but with caution, as not all advertising activities will be permitted.

In his latest article for politykazdrowia.com, Tomasz Jan Siemiński, Partner and the Leader of the Healthcare & Life Sciences Practice at Jabłoński Koźmiński & Partners, answers the following key questions:

• What is the appropriate procedure to recover paid fines?
• What marketing activities are considered safe to undertake today?
• What are the upcoming developments concerning national pharmacy advertising regulations?

The full article is available here.